Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study-Reference-Cited by-同舟云学术

Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study

Published:2017-04 Issue: Volume:97 Page:147-152
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Pedersini Rebecca,Monteverdi Sara,Mazziotti Gherardo,Amoroso Vito^ORCID,Roca Elisa,Maffezzoni Filippo,Vassalli Lucia,Rodella Filippo,Formenti Anna Maria,Frara Stefano,Maroldi Roberto,Berruti Alfredo,Simoncini Edda,Giustina Andrea

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference42 articles.

1. Tailoring therapies–improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015;Coates;Ann. Oncol.,2015

2. Drug-induced osteoporosis: mechanisms and clinical implications;Mazziotti;Am. J. Med.,2010

3. Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5years of letrozole or tamoxifen in the BIG 1–98 trial;Rabaglio;Ann. Oncol.,2009

4. Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230;Eastell;J. Clin. Oncol.,2008

5. The effect of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis of the US, German, Netherlands, and Belgium sub-studies;Hadji;J. Cancer Res. Clin. Oncol.,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies;European Journal of Endocrinology;2024-07-26

2. High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma;Pituitary;2024-05-27

3. Aromatase inhibitors and fracture prevention – do 2017 guidelines work in real world?;BJC Reports;2024-05-01

4. Management of cancer treatment–induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey;Tumori Journal;2024-03-10

5. Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer;JAMA Network Open;2024-01-10